CD19 Antilichaam [65] (PE)

CD19 is a monomeric transmembrane glycoprotein expressed at relatively constant levels throughout B cell development from early pro-B/pre-B cells (i.e. B220+/CD43+/HSA+) through fully differentiated B cell stages. Terminally differentiated plasma cells do not express CD19. In humans, the CD19 molecule on the surface of mature B cells associates with CD21 (CR-2) and CD81 (TAPA-1), and this multimolecular complex synergizes with surface immunoglobulin to provide signal transduction and promote cellular activation. All splenic and peritoneal IgM+ cells of both B-1 and B-2 lineages are CD19+, with B-1 cells expressing higher levels of CD19 than B-2 cells in these sites. Studies with CD19-deficient mice have suggested that this molecule may not be required for normal generation and maturation of B cells in the bone marrow. The monoclonal antibody 6D5 recognizes the same epitope as the published clone, 1D3.

12478

P25918

P25918

Mouse

Mouse CD19-expressing K562 human erythroleukemia cells

[6D5]

PE

Primary Antibodies

Immunology

0.1 mg/mL

Supplied in PBS/NaN3 and a stabilizing agent

None

Blue Ice

Store vial at 2-8˚ C

IgG2a

CD19

CD19 Antibody [6D5] for use in flow cytometry assays.

Cd19

CD19 antigen

Mus musculus

B4, Leu-12

ELISA, WB, IHC-P, IHC-Fr, Flow, IP, Neutralization Assay, Multiplex

Liquid